We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
Guidance for marketing authorisation holders on drafting direct healthcare professional communications (DHPCs)
Guidance for dispensing of valproate-containing medicines in the manufacturer’s original full pack, following amendments to the Human Medicines Regulations (HMRs).
The review of the safety of isotretinoin has concluded.
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Device-specific guidance for manufacturers on reporting adverse incidents under the vigilance system
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
For manufacturers reporting adverse incidents with biological/mechanical surgical heart valves under the vigilance system.
Guidance for health professionals on dealing with Listeriosis in relation to Sainsbury’s national recall of products on 26 June 2017.
The findings and recommendations of the Expert Advisory Group on paclitaxel drug-coated balloon catheters and drug-eluting stents which are used to treat patients with peripheral arterial disease.
For manufacturers reporting adverse incidents with neurostimulators under the vigilance system.
For manufacturers reporting adverse incidents with IVC filters under the vigilance system.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).